FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2043976304> ?p ?o ?g. }

• W2043976304 endingPage "137" @default.
• W2043976304 startingPage "130" @default.
• W2043976304 abstract "Treatment designed to eliminate thrombus in patients with iliofemoral deep venous thrombosis (DVT) is theoretically attractive; however, its benefits, compared with those of anticoagulation, have not been definitively demonstrated. Although not previously analyzed, an effective measure of treatment success is likely to be the assessment of health-related quality of life (HRQOL). This study evaluated whether catheter-directed thrombolysis for iliofemoral DVT is associated with improved HRQOL, compared with standard anticoagulation, and whether HRQOL outcome in the thrombolysis group is related to lytic success.An 80-item self-administered HRQOL questionnaire was developed. It contained the Health Utilities Index, Short Form-12, and disease-targeted scales, including health distress, stigma, health interference, physical functioning, and symptoms (eg, leg swelling, pain, ulcers). The HRQOL questionnaire was confirmed to be reliable and valid by means of psychometric testing. Questionnaires were administered to 98 retrospectively identified patients who had had iliofemoral DVT treated at least 6 months earlier. Sixty-eight patients who were identified through a DVT registry were treated with catheter-directed thrombolysis with urokinase (UK), and 30 patients who were identified by means of a medical record review were treated with anticoagulation alone. The treatment decision was made by the attending physician, and all patients were candidates for both thrombolysis and anticoagulation.Most patients were women (61%), white (95%), married (65%), and had a mean interval since initial DVT of 16 months. The group treated with UK was younger (53 +/- 17 years) than the group treated with heparin (61 +/- 6 years; P =.039). After treatment, patients treated with UK reported better overall physical functioning (P =.046), less stigma (P =.033), less health distress (P =.022), and fewer post-thrombotic symptoms (P =. 006), compared with the patients treated with anticoagulation alone. Within the UK group, phlebographically successful lysis correlated with improved HRQOL (P =.038). Patients classified as lytic failures had similar outcomes to patients treated with heparin.Patients with iliofemoral DVT treated with catheter-directed thrombolysis have better functioning and well-being, compared with patients treated with anticoagulation alone. Successful lysis was directly correlated with improved HRQOL, with patients who were classified as lytic failures having similar outcomes to patients treated with heparin. These data support the need for a future randomized trial, which should include an HRQOL measure as part of the outcome analysis." @default.
• W2043976304 created "2016-06-24" @default.
• W2043976304 creator A5017068586 @default.
• W2043976304 creator A5026963758 @default.
• W2043976304 creator A5037033786 @default.
• W2043976304 creator A5048850165 @default.
• W2043976304 creator A5059918466 @default.
• W2043976304 date "2000-07-01" @default.
• W2043976304 modified "2023-10-16" @default.
• W2043976304 title "Catheter-directed thrombolysis for iliofemoral deep venous thrombosis improves health-related quality of life" @default.
• W2043976304 cites W1979441861 @default.
• W2043976304 cites W1982885425 @default.
• W2043976304 cites W1984011502 @default.
• W2043976304 cites W2012042329 @default.
• W2043976304 cites W2013166904 @default.
• W2043976304 cites W2030745749 @default.
• W2043976304 cites W2032215337 @default.
• W2043976304 cites W2042529489 @default.
• W2043976304 cites W2085792515 @default.
• W2043976304 cites W2086137808 @default.
• W2043976304 cites W2094561883 @default.
• W2043976304 cites W2167955183 @default.
• W2043976304 cites W2342200163 @default.
• W2043976304 cites W4294109446 @default.
• W2043976304 cites W4328001130 @default.
• W2043976304 doi "https://doi.org/10.1067/mva.2000.105664" @default.
• W2043976304 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/10876214" @default.
• W2043976304 hasPublicationYear "2000" @default.
• W2043976304 type Work @default.
• W2043976304 sameAs 2043976304 @default.
• W2043976304 citedByCount "325" @default.
• W2043976304 countsByYear W20439763042012 @default.
• W2043976304 countsByYear W20439763042013 @default.
• W2043976304 countsByYear W20439763042014 @default.
• W2043976304 countsByYear W20439763042015 @default.
• W2043976304 countsByYear W20439763042016 @default.
• W2043976304 countsByYear W20439763042017 @default.
• W2043976304 countsByYear W20439763042018 @default.
• W2043976304 countsByYear W20439763042019 @default.
• W2043976304 countsByYear W20439763042020 @default.
• W2043976304 countsByYear W20439763042021 @default.
• W2043976304 countsByYear W20439763042022 @default.
• W2043976304 countsByYear W20439763042023 @default.
• W2043976304 crossrefType "journal-article" @default.
• W2043976304 hasAuthorship W2043976304A5017068586 @default.
• W2043976304 hasAuthorship W2043976304A5026963758 @default.
• W2043976304 hasAuthorship W2043976304A5037033786 @default.
• W2043976304 hasAuthorship W2043976304A5048850165 @default.
• W2043976304 hasAuthorship W2043976304A5059918466 @default.
• W2043976304 hasBestOaLocation W20439763041 @default.
• W2043976304 hasConcept C126322002 @default.
• W2043976304 hasConcept C139265228 @default.
• W2043976304 hasConcept C141071460 @default.
• W2043976304 hasConcept C159110408 @default.
• W2043976304 hasConcept C1862650 @default.
• W2043976304 hasConcept C2776176941 @default.
• W2043976304 hasConcept C2776892390 @default.
• W2043976304 hasConcept C2778959117 @default.
• W2043976304 hasConcept C2779134260 @default.
• W2043976304 hasConcept C2779581417 @default.
• W2043976304 hasConcept C2779951463 @default.
• W2043976304 hasConcept C2780011451 @default.
• W2043976304 hasConcept C2780868729 @default.
• W2043976304 hasConcept C3019006561 @default.
• W2043976304 hasConcept C500558357 @default.
• W2043976304 hasConcept C70410870 @default.
• W2043976304 hasConcept C71924100 @default.
• W2043976304 hasConceptScore W2043976304C126322002 @default.
• W2043976304 hasConceptScore W2043976304C139265228 @default.
• W2043976304 hasConceptScore W2043976304C141071460 @default.
• W2043976304 hasConceptScore W2043976304C159110408 @default.
• W2043976304 hasConceptScore W2043976304C1862650 @default.
• W2043976304 hasConceptScore W2043976304C2776176941 @default.
• W2043976304 hasConceptScore W2043976304C2776892390 @default.
• W2043976304 hasConceptScore W2043976304C2778959117 @default.
• W2043976304 hasConceptScore W2043976304C2779134260 @default.
• W2043976304 hasConceptScore W2043976304C2779581417 @default.
• W2043976304 hasConceptScore W2043976304C2779951463 @default.
• W2043976304 hasConceptScore W2043976304C2780011451 @default.
• W2043976304 hasConceptScore W2043976304C2780868729 @default.
• W2043976304 hasConceptScore W2043976304C3019006561 @default.
• W2043976304 hasConceptScore W2043976304C500558357 @default.
• W2043976304 hasConceptScore W2043976304C70410870 @default.
• W2043976304 hasConceptScore W2043976304C71924100 @default.
• W2043976304 hasIssue "1" @default.
• W2043976304 hasLocation W20439763041 @default.
• W2043976304 hasLocation W20439763042 @default.
• W2043976304 hasOpenAccess W2043976304 @default.
• W2043976304 hasPrimaryLocation W20439763041 @default.
• W2043976304 hasRelatedWork W22889690 @default.
• W2043976304 hasRelatedWork W2362019806 @default.
• W2043976304 hasRelatedWork W2368666077 @default.
• W2043976304 hasRelatedWork W2368737360 @default.
• W2043976304 hasRelatedWork W2369783722 @default.
• W2043976304 hasRelatedWork W2379497856 @default.
• W2043976304 hasRelatedWork W2390273518 @default.
• W2043976304 hasRelatedWork W2421632477 @default.
• W2043976304 hasRelatedWork W3029811999 @default.

• next